cormorant Lp Biography and Net Worth

cormorant Lp is the Insider of Aerovate Therapeutics.

How do I contact cormorant Management Lp?: The corporate mailing address for Lp and other Aerovate Therapeutics executives is , , . Aerovate Therapeutics can also be reached via phone at 617-443-2400 and via email at [email protected]. Learn More on cormorant Management Lp's contact information.
Has cormorant Management Lp been buying or selling shares of Aerovate Therapeutics?: cormorant Management Lp has not been actively trading shares of Aerovate Therapeutics during the past quarter. Learn More on cormorant Management Lp's trading history.
Are insiders buying or selling shares of Aerovate Therapeutics?: In the last year, insiders at the sold shares 39 times. They sold a total of 208,097 shares worth more than $4,401,916.57. The most recent insider tranaction occured on April, 17th when insider Benjamin T Dake sold 6,853 shares worth more than $153,301.61. Insiders at Aerovate Therapeutics own 19.3% of the company. Learn More about insider trades at Aerovate Therapeutics.
Information on this page was last updated on 4/17/2024.

cormorant Management Lp Insider Trading History at Aerovate Therapeutics

cormorant Management Lp Buying and Selling Activity at Aerovate Therapeutics

Aerovate Therapeutics Company Overview

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $21.94

$21.12

$22.39

50 Day Range

MA: $24.60

$18.80

$30.75

2 Week Range

Now: $21.94

$9.41

$32.42

Volume

44,029 shs

Average Volume

131,747 shs

Market Capitalization

$611.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>